SEC
SlamSEC
SearchBrowseEarnings

Unity Biotechnology, Inc.

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(464 total)

TypeDateAccessionPeriodSize
15-12G
Jan 2, 2026
0001193125-26-00037315-12G
—
10.9 KB
SCHEDULE 13G/A
Nov 14, 2025
0001012975-25-000775
—
16.6 KB
EFFECT
Sep 26, 2025
9999999995-25-003106
—
1.9 KB
EFFECT
Sep 26, 2025
9999999995-25-003105
—
1.9 KB
8-K
Sep 26, 2025
0001193125-25-2207788-K
Sep 24, 2025
217.3 KB
POS AM
Sep 25, 2025
0001193125-25-217438POS AM
—
22.2 KB
POS AM
Sep 25, 2025
0001193125-25-217435POS AM
—
22.2 KB
8-K
Sep 19, 2025
0001193125-25-2092108-K
Sep 18, 2025
148.1 KB
S-8 POS
Aug 25, 2025
0001193125-25-187696S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187694S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187693S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187689S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187687S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187684S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187679S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187672S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187666S-8 POS
—
32.5 KB
S-8 POS
Aug 25, 2025
0001193125-25-187664S-8 POS
—
32.5 KB
DEF 14A
Aug 11, 2025
0001140361-25-030046DEF 14A
Sep 18, 2025
1.8 MB
25-NSE
Aug 6, 2025
0001354457-25-000770
—
3.7 KB
PRE 14A
Aug 1, 2025
0001140361-25-028272PRE 14A
Sep 18, 2025
1.8 MB
DEFA14A
Jul 24, 2025
0001193125-25-164404DEFA14A
—
76.5 KB
8-K/A
Jul 24, 2025
0001193125-25-1644008-K/A
Jul 21, 2025
254.4 KB
DEFA14A
Jul 22, 2025
0001193125-25-162542DEFA14A
—
75.2 KB
8-K
Jul 22, 2025
0001193125-25-1625378-K
Jul 21, 2025
215.3 KB
25 filings shown

Unity Biotechnology, Inc. was a publicly traded American biotechnology company that develops drugs that target senescent cells.